“…Recently, mutations in three FA genes, including FANCD1/BRCA2 , FANCM , and FANCU/XRCC2 (Howlett et al, 2002; Shamseldin, Elfaki, & Alkuraya, 2012; Singh et al, 2009), have been identified in patients with POI (Fouquet et al, 2017; Qin, Zhang, & Chen, 2019; Weinberg‐Shukron et al, 2018; Zhang et al, 2019), thus suggesting the importance of the FA pathway in ovarian development and function. Ubiquitination of the FANCI‐D2 complex is a key event in this pathway, and thus failure of ubiquitination due to impaired function of FANCL will prevent the activation of the FA pathway (Wang & Smogorzewska, 2015).…”